These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 15497100)

  • 1. Platelet dysfunction in renal failure.
    Boccardo P; Remuzzi G; Galbusera M
    Semin Thromb Hemost; 2004 Oct; 30(5):579-89. PubMed ID: 15497100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of bleeding in dialysis patients.
    Galbusera M; Remuzzi G; Boccardo P
    Semin Dial; 2009; 22(3):279-86. PubMed ID: 19573008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet dysfunction and end-stage renal disease.
    Kaw D; Malhotra D
    Semin Dial; 2006; 19(4):317-22. PubMed ID: 16893410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uremic platelet dysfunction: past and present.
    Escolar G; Díaz-Ricart M; Cases A
    Curr Hematol Rep; 2005 Sep; 4(5):359-67. PubMed ID: 16131436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dysfunction of platelets in uremia].
    Hryszko T; Małyszko J; Myśliwiec M
    Przegl Lek; 1999; 56(9):599-603. PubMed ID: 10695367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disorders of hemostasis in chronic renal failure and renal transplantation].
    Goluza E; Topalović MG; Hudolin T; Konosić S; Kocman IB; Perić M
    Acta Med Croatica; 2011; 65(4):337-47. PubMed ID: 22359906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case of uremic platelet dysfunction].
    Ohzeki M; Fukushima T; Arakawa S; Ozeki M; Kosaka Y; Kobayashi S; Namikoshi T; Haruna Y; Sasaki T; Kashihara N
    Nihon Jinzo Gakkai Shi; 2005; 47(7):834-8. PubMed ID: 16296414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet function in patients on maintenance hemodialysis: depressed or enhanced?
    Remuzzi G; Benigni A; Dodesini P; Schieppati A; Gotti E; Livio M; Mecca G; Donati B; de Gaetano G
    Clin Nephrol; 1982 Feb; 17(2):60-3. PubMed ID: 7067167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.
    Soyoral YU; Demir C; Begenik H; Esen R; Kucukoglu ME; Aldemir MN; Demirkiran D; Erkoc R
    Clin Appl Thromb Hemost; 2012; 18(2):185-8. PubMed ID: 22327827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
    Elshamaa MF; Elghoroury EA; Helmy A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis shortens long in vitro closure times as measured by the PFA-100.
    Bilgin AU; Karadogan I; Artac M; Kizilors A; Bligin R; Undar L
    Med Sci Monit; 2007 Mar; 13(3):CR141-5. PubMed ID: 17325638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acquired platelet function disorders: pathogenesis, classification, frequency, diagnosis, clinical management].
    Scharf RE
    Hamostaseologie; 2008 Dec; 28(5):299-311. PubMed ID: 19132161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostatic changes in patients with end stage renal disease undergoing hemodialysis.
    Rios DR; Carvalho Md; Lwaleed BA; Simões e Silva AC; Borges KB; Dusse LM
    Clin Chim Acta; 2010 Feb; 411(3-4):135-9. PubMed ID: 19945449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of uremic patients with high bleeding risk].
    Ogata H; Kinugasa E
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():70-4. PubMed ID: 15250271
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet associated IgG in uremia.
    Thomsen S; Giuliani D; Chang D; Lasker N; Morse BS
    Clin Nephrol; 1983 Sep; 20(3):136-9. PubMed ID: 6685006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombocytopathy and blood complications in uremia].
    Hörl WH
    Wien Klin Wochenschr; 2006 Apr; 118(5-6):134-50. PubMed ID: 16773479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation.
    Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J
    Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The decreased circulating platelet mass and its relation to bleeding time in chronic renal failure.
    Michalak E; Walkowiak B; Paradowski M; Cierniewski CS
    Thromb Haemost; 1991 Jan; 65(1):11-4. PubMed ID: 2024233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.